Janux Therapeutics Inc
JANX
Market Cap$1.94B
Close$
$4.73
82.1% downside
Current Fair Value
82.1% downsideOvervalued by 82.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.94 Billion |
|---|---|
| Enterprise Value | $1.54 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.28 |
| Beta | 3.27 |
| Outstanding Shares | 56,832,374 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -27.08 |
|---|---|
| PEG | -19 |
| Price to Sales | - |
| Price to Book Ratio | 1.55 |
| Enterprise Value to Revenue | 117.69 |
| Enterprise Value to EBIT | -17.87 |
| Enterprise Value to Net Income | -26 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Janux Therapeutics Inc
16 employees